Preclinical Research

News Headlines

On your radar

All news articles

News headlines > Preclinical Research

Email this page News by email Send a press-release

Preclinical services news in brief

15-Nov-2007 - In this week's review of activity within the preclinical research services arena, news has emerged involving GATC Biotech, NextGen Sciences and Genedata.

Evotec's metamorphosis erodes profit

14-Nov-2007 - Evotec's bid to distance itself from being a services business and eventually morph into a fully fledged pharma company has been felt on the company's balance sheet during the third quarter.

China CRO attracts $30m US investment

12-Nov-2007 - China's second largest contract research organisation (CRO) ShangPharma has attracted $30m (€21m) from US private investment firm TPG as the Asian pharma market continues to simmer.

Tripos lands Schering-Plough deal

12-Nov-2007 - Tripos Discovery Research (TDR) has risen from the ashes surrounding the liquidation of its previous owners Tripos, Inc. to land a 'library enrichment' deal with Schering-Plough.

'World's first' NanoImaging service centre opens

08-Nov-2007 - NanoImaging Services has opened what it claims is a first of its kind fee-for-service imaging business to enable structural characterisation and validation of biological drugs throughout the development pipeline.

Preclinical services news in brief

07-Nov-2007 - In this week's review of activity within the preclinical research services arena, new deals have emerged involving MDS Pharma Services, Bruker Biospin and Expression Analysis.

Charles River sails through Q3

06-Nov-2007 - Charles River Laboratories sailed through its third quarter, with comfortable gains in both revenue and profits.

Sigma-Aldrich halves miRNA preparation times

05-Nov-2007 - Sigma-Aldrich has continued its push into the RNAi field with the launch of its new mirPremier miRNA (microRNA) isolation kit that promises to speed up miRNA preparation while removing all large, unwanted RNA.

EU considers Afghan poppy pilot

05-Nov-2007 - A proposed pilot programme to divert Afghanistan's infamous and illegal opium supply for legal use in analgesics has been backed by the European Parliament but is facing fierce criticism elsewhere.

GSK blocks new patent rules

01-Nov-2007 - Just a day before they were due to come into force, GlaxoSmithKline has won a court case to block controversial changes to patent rules.

Big pharma reaches to Summit for zebrafish safety screening

30-Oct-2007 - Summit (formerly VASTox) has signed a $450,000 (€312,000) deal with one of the world's top five pharma firms to enable it to use Summit's zebrafish-platform in its drug safety programme.

J&J, Galapagos sign deal to search for arthritis 'Holy Grail'

24-Oct-2007 - Belgian biotech Galapagos has penned 'by far' its biggest ever deal, with Johnson & Johnson (J&J) committing an estimated €1bn to a joint arthritis research programme.

Pfizer not alone in feeling the heat of California fires

24-Oct-2007 - As the fires in California continue to rage, Pfizer and other pharma and biotech companies all over Southern California are bracing themselves for closures and even evacuations of their facilities.

Preclinical services news in brief

23-Oct-2007 - In this week's review of activity within the preclinical research services arena, new deals have emerged involving Cato Research, Genoway, Caliper Life Sciences and Rules-Based Medicine.

Discarded body parts used to cut animal testing

19-Oct-2007 - A team of US scientists have used typically discarded body parts to create a 'joint in a test tube', which can be used to test arthritis drugs instead of using animals.

Study your rats so the results don't bite

19-Oct-2007 - New research has shown that even if laboratory rats are genetically identical they can still develop distinct metabolic profiles that could skew drug toxicity and metabolism studies.

Online drug discovery services database to be launched

18-Oct-2007 - A US start-up firm is gearing up to launch an online database where researchers can access a variety of drug discovery service providers across the globe.

Preclinical presence in Asia continues to gain momentum

17-Oct-2007 - The activity of local and international firms establishing preclinical testing services to good laboratory practice (GLP) standards in Asia continues to gain momentum.

Boehringer hopes cash injection will turbocharge diabetes and obesity programme

16-Oct-2007 - Boehringer Ingelheim has witnessed Vitae Pharmaceuticals attack the same diabetes and obesity target as itself, only faster, and has decided to splash out for a piece of the action.

Galapagos gains grants of €5.2m

16-Oct-2007 - Galapagos and its services division BioFocus DPI have gained three new research grants totalling €5.2m.

GSK's disdain is blatant over new rules for patent

15-Oct-2007 - GlaxoSmithkline (GSK) has expressed its disdain for looming changes to drug patent application rules in the US and has launched a lawsuit to try and stop them coming into force next month.

Kinaxo adds new proteomics service

11-Oct-2007 - Kinaxo Biotechnologies is now offering a new proteomics service to help drug developers decide which drug candidates to move through the preclinical process.

China luring preclinical players

10-Oct-2007 - China is one of the best destinations to outsource preclinical work, delegates heard at this year's CPhI trade how in Milan.

RBM buys EDI, simplifies immune response testing

10-Oct-2007 - Biomarker testing service provider Rules-Based Medicine (RBM) has bought EDI to gain access to its 3D organ-like and ex vivo cell culture test systems to aid its preclinical and clinical research programmes.

Rumours of Pfizer, Sanofi mega-merger emerge

09-Oct-2007 - Rumours that Pfizer is looking into buying a large stake in Sanofi-Aventis, which could be seen as a prelude to a full takeover bid, has prompted a flurry of shareholder activity.